DE60017174D1 - Rivastigmine zur behandlung von augenerkrankungen - Google Patents

Rivastigmine zur behandlung von augenerkrankungen

Info

Publication number
DE60017174D1
DE60017174D1 DE60017174T DE60017174T DE60017174D1 DE 60017174 D1 DE60017174 D1 DE 60017174D1 DE 60017174 T DE60017174 T DE 60017174T DE 60017174 T DE60017174 T DE 60017174T DE 60017174 D1 DE60017174 D1 DE 60017174D1
Authority
DE
Germany
Prior art keywords
rivastigmine
treatment
eye diseases
diseases
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60017174T
Other languages
English (en)
Other versions
DE60017174T2 (de
Inventor
David Goldblum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE60017174D1 publication Critical patent/DE60017174D1/de
Application granted granted Critical
Publication of DE60017174T2 publication Critical patent/DE60017174T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
DE60017174T 1999-10-19 2000-10-17 Rivastigmine zur behandlung von augenerkrankungen Expired - Lifetime DE60017174T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99120678 1999-10-19
EP99120678 1999-10-19
PCT/EP2000/010234 WO2001028553A1 (en) 1999-10-19 2000-10-17 Rivastigmine for the treatment of ocular disorders

Publications (2)

Publication Number Publication Date
DE60017174D1 true DE60017174D1 (de) 2005-02-03
DE60017174T2 DE60017174T2 (de) 2005-12-22

Family

ID=8239225

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60017174T Expired - Lifetime DE60017174T2 (de) 1999-10-19 2000-10-17 Rivastigmine zur behandlung von augenerkrankungen

Country Status (13)

Country Link
US (2) US6534541B1 (de)
EP (1) EP1225890B1 (de)
JP (1) JP2003512324A (de)
AR (1) AR026062A1 (de)
AT (1) ATE285764T1 (de)
AU (1) AU766001B2 (de)
CA (1) CA2384690C (de)
DE (1) DE60017174T2 (de)
DK (1) DK1225890T3 (de)
ES (1) ES2234708T3 (de)
NZ (1) NZ518164A (de)
PT (1) PT1225890E (de)
WO (1) WO2001028553A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141762A0 (en) 1998-10-01 2002-03-10 Novartis Ag New oral formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
CN107417574B (zh) * 2017-03-21 2019-12-03 浙江省医学科学院 2,4-双取代苯乙酮化合物及其旋光异构体、药学上可接受的盐及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74497A (en) 1985-03-05 1990-02-09 Proterra Ag Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives
HU201906B (en) 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
US4900748A (en) 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
EP0605474B1 (de) 1991-09-26 2003-11-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES Carbamatanalogen von thiaphysovenin, pharmazeutische zusammensetzungen und verfahren zur hemmung von cholinesterasen
WO1993006105A1 (en) 1991-09-26 1993-04-01 United States Government, As Represented By Secret Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
AU1138097A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of prostaglandins and miotics for lowering intraocular pressure

Also Published As

Publication number Publication date
ES2234708T3 (es) 2005-07-01
US20030119832A1 (en) 2003-06-26
US6835748B2 (en) 2004-12-28
AU766001B2 (en) 2003-10-09
ATE285764T1 (de) 2005-01-15
DK1225890T3 (da) 2005-04-04
JP2003512324A (ja) 2003-04-02
US6534541B1 (en) 2003-03-18
NZ518164A (en) 2003-10-31
EP1225890A1 (de) 2002-07-31
EP1225890B1 (de) 2004-12-29
WO2001028553A1 (en) 2001-04-26
AR026062A1 (es) 2002-12-26
CA2384690C (en) 2010-08-17
DE60017174T2 (de) 2005-12-22
CA2384690A1 (en) 2001-04-26
PT1225890E (pt) 2005-05-31
AU2834901A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69903543T2 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
ATE285764T1 (de) Rivastigmine zur behandlung von augenerkrankungen
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE69924284D1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN